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Abstract
Furan is a toxic organic compound which is usually used in industry where it helps
in the production of nylon, lacquers, insecticides, or pharmaceuticals. But it has also
been found in certain foods, mainly those that undergo heat treatment, such as tinned
and jarred food including sauces, vegetables, and baby food (European Food Safety
Authority, 2004; Jestoi et al., 2009; U.S. Food and Drug Administration, 2004). Furan
has been shown to induce liver tumors and cholangiocarcinomas (Burka et al., 1991).
As of 1995 furan is classified as ”possibly carcinogenic to humans (Croup 2B)” by the
International Agency for Research on Cancer (IARC). However, the mechanisms of
furan toxicity are still unknown. Studies have yielded different results as to whether
or not it shows genotoxic activity. It is also suspected that the genotoxic effects shown
by some studies were induced by the toxic metabolite cis-2-butene-1,4-dial (Burka
et al., 1991; Peterson et al., 2006). Genotoxic carcinogens can cause cancer in very low
doses, as even a single DNA adduct may lead to a mutation that causes cancer. For
risk assessment purposes it is therefore highly important to know what mechanisms of
action are involved in furan carcinogenesis.
In this work I was trying to characterise the mechanisms of furan toxicity by identifying
genes conferring furan resistance to previously generated C. elegans mutants. Further-
more, I looked at the visible effects of furan on C. elegans and the induction of genes
known to be involved in stress response pathways.
Frozen stocks of mutant worms were thawed and L4 larvae incubated in furan for four
days. The number of offspring was then counted and compared to N2 wild type worms.
Several changes had to be made to the original protocol, but furan resistance could not
be confirmed for any of the frozen stocks. It was found that 90 mM furan kills adult
worms so the following experiments were done with concentrations ranging from 0 to 80
mM furan. To further characterise the toxic effects of furan on C. elegans, GFP reporter
strains were used to monitor gene induction following incubation in furan. Several genes
were assayed, which are known to be involved in C. elegans stress response. In addition,
the effects of furan on growth and feeding were investigated. None of the genes tested
in the GFP reporter assay showed induction after exposure of C. elegans to furan.
However, it could be shown that furan affects C. elegans feeding and growth.
Since furan resistance could not be confirmed for any of the frozen stocks, SNP mapping
and subsequent whole genome sequencing could not be done to identify the mutation.
It could be shown that furan has an inhibitory effect on C. elegans feeding, egg laying,
and growth. Feeding is inhibited in a dose-dependent manner with an EC50 of about 70
mM. C. elegans completely stop feeding at 80 mM. Similarly, egg laying is inhibited in
a dose-dependent manner with an EC50 of about 20 mM. Growth seems to be affected
by furan as well. However, these results could not be confirmed yet. Unfortunately,
none of the genes tested in the GFP reporter assay was induced, so it was not possible
to identify any proteins affected by furan toxicity.
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1 Introduction and Literature Review
1.1 Introduction to Toxicology
The term ”toxicology” was derived from the Greek words ”toxicos” (poisonous) and
”logos” (study). It was first used in the 17th century and describes the study of harmful
interactions between chemicals and biological systems. Toxic substances can be for ex-
ample drugs, food additives, pesticides, industrial chemicals, environmental pollutants,
natural toxins, or household poisons. Interactions are not only possible with animals
or humans, but also with plants, microbes, and whole ecosystems. The toxic effect
of certain plants was already known in China more than 3000 years ago. However, it
was only in the 19th century that Justus von Liebig (1803-1873) understood the im-
portance of studying the relationship between cause and effect. In 1847 animal testing
was introduced by Rudolf Buchheim. Since then the area of toxicology has developed
rapidly (Reichl, 2009).
In 1973 the International Union of Pure and Applied Chemistry (IUPAC) (1993) estab-
lished a Commission on Toxicology which later defined globally acceptable definitions
of terms used in toxicology and ecotoxicology. They made up a glossary from which
the following terms that are important for my work are derived:
Toxicity is defined as the capacity to cause injury or the adverse effects on a living
organism. There should be a reference to the quantity of substance administered or
absorbed, the way in which the substance is administered (e.g. inhalation, ingestion,
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topical application, injection) and distributed in time (single or repeated doses), the
type and severity of injury, the time needed to produce the injury, the nature of the
organism(s) affected, and other relevant conditions. Therefore, further definitions are
required.
There is a difference between acute and chronic toxicity. Acute toxicity comprises
the adverse effects occurring within a short time (usually up to 14 days) after admin-
istration of a single dose or exposure to a given concentration of a test substance, or
after multiple doses or exposures within 24 hours. In contrast, chronic toxicity are
the adverse effects following continued exposures occurring over an extended period of
time.
The effective concentration (EC) is the concentration of a substance that causes a
defined magnitude of response in a given system, e.g. the EC50 is the median concen-
tration that causes 50 % of maximal response. In a similar way, the median lethal
dose (LD50) can be defined. These values can be used to compare the potency of two
toxins.
The lowest observed adverse effect level (LOAEL) is the lowest concentration or
amount of a substance, found by experiment or observation, which causes an adverse
alteration of morphology, functional capacity, growth, development, or life span of a
target organism distinguishable from normal (control) organisms of the same species
and strain under defined conditions of exposure. The no observed adverse effect
level (NOAEL) therefore is the concentration of a substance at which there is no
biologically or statistically significant increase in the frequency or severity of any ad-
verse effects. The possibility that a harmful event (death, injury, or loss) arising from
exposure to a chemical or physical agent may occur under specific conditions is referred
to as risk. The identification and quantification of the risk, taking into account pos-
sible harmful effects on individual people or society of using the chemical or physical
agent in the amount and manner proposed and all the possible routes of exposure, is
10
called risk assessment. For risk assessment purposes, it is important to define an
acceptable daily intake (ADI). This is an estimate of the amount of a substance in
food or drinking water which can be ingested daily over a lifetime by humans without
appreciable health risk. To calculate the ADI, the NOAEL is devided by a safety factor
(usually 100) to account for differences between animals and humans (factor 10) and
differences between humans (also factor 10). The ADI is generally expressed in mg/kg
body weight (bwt). For calculation of the daily intake per person, a standard body
mass of 60 kg is used.
1.2 Caenorhabditis elegans
C. elegans belongs to the phylum Nematoda (roundworms). Nematodes are a very
diverse phylum with species ranging in length from less than 1 mm to over 35 cm.
They are either free living or parasites of plants or animals, including humans, and can
be found in almost all living environments. C. elegans usually lives in the pore water of
soils and feeds mostly on bacteria. It has also been found on rotten fruit from compost
samples, presumably because they contain high numbers of bacteria (Barrie`re & Fe´lix,
2006).
Figure 1.1: Electron micrograph of C. elegans. The image shows an adult hermaphrodite
lying on its right lateral side (http://www.wormatlas.org).
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1.2.1 C. elegans anatomy
C. elegans is about 1 mm long, transparent, and has a cylindrical body shape with
conical ends (Figure 1.1, page 11). The anatomy of C. elegans is very simple. The
body is unsegmented and consists of two concentric tubes. The outer tube consists of
the cuticle, hypodermis, excretory system, neurons, and muscles and the inner tube
comprises the pharynx, intestine, and gonads (in adults only). The space between
the tubes is called pseudocoelomic space (Strange, 2006; Wood, 1988; WormAtlas,
29/04/2010). The general nematode body plan is shown in Figure 1.2.
Figure 1.2: Body plan and cross sections of C. elegans from head to tail. A. Posterior
body region. Body wall (outer tube) is separated from the inner tube (alimentary
system, gonad) by a pseudocoelom. B. Anterior head. C. Middle of head. D.
Posterior head. E. Posterior body. (DNC) Dorsal nerve cord; (VNC) ventral nerve
cord. F. Tail, rectum area (http://www.wormatlas.org).
Contraction of the subventral muscles with simultaneous relaxation of the subdorsal
muscles and vice versa results in sinusoidal movement (Riddle et al., 1997). On an agar
dish the worms move on either lateral side.
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1.2.2 Life cycle of C. elegans
C. elegans has a relatively short life cycle under laboratory conditions (Figure 1.3).
It consists of an embryonic stage, four larval stages (L1-L4), and adulthood which is
reached after 31
2
days at 20 ◦C (Brenner, 1974). Eggs are roughly 30 x 50 µm in
size. They develop internally for six hours before being laid. L1 larvae hatch after a
further eight hours or so. During larval development the old cuticle is replaced by a
stage-specific new one after each larval stage; this process is termed moulting. Adults
produce eggs for several days and the average life span is about 2-3 weeks (Lewis &
Fleming, 1995; Riddle et al., 1997).
Figure 1.3: Life cycle of C. elegans at 25◦ C. (http://www.wormatlas.org)
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1.2.3 The dauer stage
If the population density is too high and food is scarce, C. elegans larval development
is arrested at the end of L1 /early L2 stage and the animals enter a “dauer” stage
(Figure 1.3, page 13). Three environmental factors lead to the formation of dauer
larvae. A pheromone produced by all C. elegans individuals serves as a measure of
population density. A high population density and decreased availability of food as
well as an increase in temperature result in an arrest in development and aging. Dauer
larvae have distinguishable morphological and behavioral characteristics. Their energy
metabolism is altered, they do not feed, and pharyngeal pumping is suppressed. The
ability to move is maintained, but dauer larvae often lie motionless. A special cuticle
is developed which gives resistance to detergent treatment (e.g. 1 % SDS) and dehy-
dration. Dauer larvae are able to survive for several months by utilising food stored
in intestinal granules. However, the dauer stage does not affect postdauer life span.
In response to improved environmental conditions and an increase in food availability
dauer larvae resume growth and normal development usually within an hour (Hu, 2007;
Riddle, 1988).
1.2.4 C. elegans genetics
C. elegans is diploid and has five pairs of autosomes (I-V) and one pair of sex chromo-
somes (X). Adult C. elegans are hermaphrodite (referred to as XX) or male (referred
to as X0) (Figure 1.4, page 15). However, males comprise only about 0.1 % of all
individuals in the reference Bristol N2 strain and 1 % in the Hawaiian CB4856 strain.
They arise because of X-chromosome nondisjunction. Reproduction occurs either by
self-fertilisation in hermaphrodites, which produces about 300 progeny, or sexually by
mating with males, the latter producing more than 1000 progeny. The hermaphrodite
has 959 somatic cells whereas the male worm has 1031 somatic cells (Strange, 2006;
14
Wood, 1988). A number of him (high incidence of males) mutants showing an increased
frequency of self-progeny males has been identified Hodgkin et al. (1979).
Figure 1.4: C. elegans male (top) and hermaphrodite (bottom). Males have a fan-
shaped tail which makes it easy to distinguish them from hermaphrodites (modified
from http://www.wormatlas.org).
The genome of C. elegans has a size of about 100 Mb. In 1998 C. elegans became the
first multicellular organism for which the whole genome was sequenced. Genes make
up about 40 % of the genome with a significant number arranged in operons; overall
25 % of the genome seems to be protein-coding (Hodgkin, 2005).
Normally, about 10−6 mutations per gene per generation occur. Mutations can be easily
generated, e.g. with EMS (ethyl methanesulfonate) or other chemical mutagens such
as nitrosoguanidine (NTG), diethyl sulfate, diepoxybutane (DEB) or formaldehyde.
Exposure to gamma radiation, X-radiation or ultraviolet (UV) radiation also causes
mutations. As only mutations in the germ line are passed on to the offspring, usually
late L4 larvae or young adults are mutagenised (Anderson, 1995).
1.2.5 C. elegans as a model organism
Research into the biology of C. elegans began in 1963 when the molecular biologist
Sydney Brenner started to look for a multicellular organism that could be used to
study the development of the nervous system genetically. It has been used as a model
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organism ever since. C. elegans has several advantages such as a short life cycle, small
genome, constant somatic cell number, and large number of progeny. It can be grown
on agar plates with E. coli as a food source which makes it easy to handle in the
laboratory. Due to its transparency it can be easily looked at under a normal light
microscope (Brenner, 1974; Wood, 1988). C. elegans is also a good model to investi-
gate toxicity. Growth, size, number of offspring, behaviour, mortality, and changes in
appearance or movement can all be monitored. A great number of toxicity assays have
been developed, providing the basis for a number of studies on different toxins (Bishof
et al., 2006; Ura et al., 2002). A variety of other tools are also available to look at
changes at the genetic level, including transgenic reporter strains, microarrays, and
RNA interference (Lindblom & Dodd, 2006).
Sydney Brenner shared the 2002 Nobel Prize in Physiology or Medicine with J. Sul-
ston and H.R. Horvitz “for their discoveries concerning ’genetic regulation of organ
development and programmed cell death’ ” (Nobel Foundation, 2002).
GFP reporter strains
The green fluorescent protein (GFP) is a small protein that was originally isolated from
the jellyfish Aequorea victoria. The 27 kDa protein is composed of a central α-helix
containing the chromophore surrounded by an eleven stranded cylinder of antiparallel
β-sheets. The chromophore is formed from residues 65-67 (Ser-Tyr-Gly) in the native
protein. GFP absorbs UV light with a major excitation peak at 395 nm and blue light
with a minor excitation peak at 475 nm, and it emits green light (509 nm). In addition
to the wild type protein, several mutants of GFP have been engineered which have
improved properties such as increased fluorescence or shifted absorbance and emission
spectra. It does not need any enzymatic substrates, which reduces the impact on the
experiment in which it is used. The GFP gene is often fused to target genes to monitor
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gene expression or to locate proteins in cells (Tsien, 1998).
Table 1.1 shows the GFP reporter strains that were used in this project.
Table 1.1: List of candidate genes for the GFP reporter assay. The information is
summarised from WormBase (29/04/2010).
Strain Gene Description
JR2474 cep-1 cep-1 encodes an ortholog of the human tumor suppressor
p53 that promotes DNA damage-induced apoptosis and is
required for normal meiotic segregation in the germ line.
It also affects sensitivity to hypoxia-induced lethality and
longevity in response to starvation. CEP-1 appears to
be ubiquitous throughout embryonic development. After
hatching, expression is restricted to a subset of pharynx
cells.
BC20334 cyp-29A2 cyp-29A2 encodes a cytochrome P450. Semi-quantitative
RT-PCR showed the elevated gene expression level after
PCB52 treatment. cyp-29A2 is expressed in pharynx, intes-
tine, body wall muscle, hypodermis, nervous system, head
and tail neurons.
BC20306 cyp-34A9 cyp-34A9 encodes a cytochrome P450. cyp-34A9 is ex-
pressed in the intestine.
pPD97 87-
35A2prIII-
GFP
cyp-35A2 cyp-35A2 encodes a cytochrome P450. cyp-35A2 mRNA
is upregulated in response to treatment with xenobiotics,
such as PCBs or PAHs . Loss of cyp-35A/C gene family
activity in the presence of xenobiotics can diminish the re-
productive decline seen in wild type worms treated with
the same compounds. cyp-35A(RNAi) also results in a re-
duction of fat content. cyp-35A2 reporter gene fusions are
strongly expressed in the intestine following treatment with
xenobiotics. The basal level of expression, if any, was below
the sensitivity of the fluorescence microscopy method.
BC20305 C11E4.1
(GPB)
C11E4.1 is a gene with a glutathione peroxidase domain.
It is expressed in pharynx, intestine, rectal gland cells, hy-
podermis, and unidentified cells in the head.
BC20316 gst-1 gst-1 encodes a putative glutathione S-transferase. GST-
1 is required for sperm to normally migrate towards
a PUFA-based signal exuded by oocytes. gst-1(RNAi)
hermaphrodites are infertile, both through aberrant loss of
their own sperm and through failure of males to effectively
inseminate them.
Continued on next page
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Table 1.1 – continued from previous page
Strain Gene Description
BC20330 gst-4 gst-4 encodes a putative glutathione-requiring
prostaglandin D synthase. GST-4 is required for sperm to
normally migrate towards a PUFA-based signal exuded by
oocytes. gst-4(RNAi) hermaphrodites are infertile, both
through aberrant loss of their own sperm and through
failure of males to effectively inseminate them. Larval
Expression: pharynx, nervous System, head neurons;
Adult Expression: pharynx, reproductive system, vulval
muscle, nervous system, head neurons. Accumulation in
adults increases in response to paraquat.The transgene
Ce-GST-p24 seems to be stage-specifically expressed, since
the GFP expression was stronger in larvae than in adults
and totally lacking in embryos.
BC20308 hsp-3 hsp-3 encodes a heat shock response 70 (hsp70) protein or-
thologous to human glucose regulated protein 78. HSP-3
likely functions as a molecular chaperone, and is expressed
constitutively throughout development with greatest abun-
dance during the L1 larval stage. Larval Expression: pha-
ryngeal gland cells, intestine, stomato-intestinal muscle,
nervous system, head and tail neurons, and unidentified
cells in tail. Adult Expression: pharyngeal gland cells, in-
testine, stomato-intestinal muscle, coelomocytes, nervous
system, head and tail neurons, and unidentified cells in tail.
HSP-3 contains a long hydrophobic amino terminus and a
carboxyl terminal KDEL sequence suggesting that it may
be retained in the endoplasmic reticulum.
CL2050 hsp-16.2 hsp-16.2 encodes a 16-kD heat shock protein (HSP) that is
a member of the hsp16/hsp20/alphaB-crystallin (HSP16)
family of heat shock proteins. hsp-16.2 expression is in-
duced in response to heat shock or other environmental
stresses. HSP-16.2 is likely to function in temporarily pre-
venting unfolded proteins from aggregating. It is ubiqui-
tously expressed throughout most somatic tissues of larvae
after heat shock, and the intensity gradually decreases with
age. HSP-16 labelling is prominent in spermathecae and in
the vulval region in L4 and adult hermaphrodites. hsp-16.2
expression is strongest in intestine and pharynx.
BC20350 sod -1 sod -1 encodes the Cu2+/Zn2+ SOD, which protects cells
from oxidative damage. sod-1 activity has been implicated
in the increased life-span of dauer larvae where this en-
zyme demonstrates the highest activity compared to other
life-stages. Unlike other eukaryotic SODs, sod-1 does not
require the copper chaperone CCS for its activity and in-
stead uses a glutathione pathway for acquiring copper. The
protein is ubiquitously expressed throughout most tissues
of the wild-type animals.
Continued on next page
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Table 1.1 – continued from previous page
Strain Gene Description
CF1553 sod -3 sod -3 encodes a Fe2+/Mn2+ SOD, predicted to be mito-
chondrial, that might defend against oxidative stress and
promote normal lifespan. sod-3 mRNA levels are dimin-
ished by mutation of daf-16 and chromatin immunoprecip-
itation (ChIP) studies demonstrate that DAF-16 can di-
rectly bind the sod-3 promoter. In wild-type animals, the
SOD-3::GFP protein is expressed constitutively in pharyn-
geal and intestinal cells. SOD-3::GFP was observed to be
expressed mainly in the head and tail of C. elegans SOD-
3::GFP distributed in a punctuate pattern, which is typical
of localization in the mitochondria.
BC20333 sod -4 sod -4 encodes an extracellular Cu2+/Zn2+ SOD. Genetic
analyses indicates that sod-4 is required for redox regula-
tion of a number of processes. Large-scale expression stud-
ies indicate that sod-4 is expressed in the nervous system,
intestine, and rectal gland cells; sod-4 transcripts are sig-
nificantly upregulated in dauers.
1.2.6 C. elegans on the internet
A lot of C. elegans data is available on the internet free of charge. These online
resources not only provide a general introduction into nematode biology, but also enable
researchers to share information and data.
WormBase is the database of the model organism C. elegans and related nematodes and
can be used to access comprehensive gene information. Wormbase is an ongoing project
which is updated every two weeks. Each release is assigned a new version number. In
this work the latest information was obtained from release WS213. Datasets are frozen
at regular intervals to enable researchers to work with the same set of data for a longer
period of time. The Ensemble genome browser also uses these frozen datasets. Worm-
Book is a collection of original, peer-reviewed articles on the biology of C. elegans and
other nematodes. It includes protocols for nematode research (WormMethods) and the
”Worm Breeder’s Gazette”, a biannual newsletter. WormAtlas provides an anatomical
database with descriptions, schemes, and an electron micrograph database. The C. el-
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egans Gene Knockout Consortium produces deletion alleles for gene targets requested
by any researcher or laboratory. Strains produced by the consortium are freely avail-
able to anyone and they are usually distributed by the Caenorhabditis Genetics Center
(CGC). Information generated by the Consortium is entered into Wormbase and can
be accessed from there.
1.3 Metabolism of Xenobiotics
Xenobiotics are substances that are not normally present in an organism. These can
include drugs or natural compounds that were taken up from the environment, but they
do not necessarily have an adverse effect. Xenobiotics are metabolised by a variety of
enzymes, dependent on their location in the body and on their chemical properties.
The main purpose of metabolism of xenobiotic substances is to eliminate them from
the body.
Due to their natural living environment, C. elegans and other free living nematodes are
under high selective pressure for detoxification mechanisms. In addition to behavioral
patterns such as sensing the presence of certain chemicals or pathogenic bacteria, a
variety of pathways have been developed to metabolise different chemicals. C. elegans
has a large number of genes encoding detoxification enzymes such as cytochromes P450,
dehydrogenases, glutathione S-transferases, as well as other transferases that might
also be involved in detoxification processes (Lindblom & Dodd, 2006). This makes C.
elegans an ideal model organism to study the effects and the metabolism of xenobiotics.
Chemicals might have effects on growth, size, number of offspring, behaviour, mortality,
appearance, or movement of C. elegans. By using microarrays or GFP reporter strains
the up- and downregulation of genes in response to different concentrations of chemicals
can be monitored (de Pomerai et al., 2010). Both approaches can give an insight into
how a chemical acts and how it is metabolised in the body.
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Xenobiotic metabolism can be divided in two phases: phase I and phase II. Some of the
most important enzymes involved in phase I and phase II metabolism are listed below.
1.3.1 Phase I metabolism
In phase I metabolism chemicals are altered in order to either eliminate them directly
or prepare them for phase II metabolism. Two classes of enzymes mainly catalyse the
reactions of phase I metabolism, the cytochromes P450 and the short chain dehydro-
genases/reductases (Lindblom & Dodd, 2006).
Cytochromes P450
Xenobiotics that are lipophilic and chemically inert usually have to be oxidised to a
more polar form before they can be eliminated. Cytochromes P450 are the most com-
mon and most important of all metabolic enzymes involved in oxidation. They comprise
a superfamily of heme-containing NADPH-dependent monoxygenases. In humans, cy-
tochromes P450 are found in many different tissues but the highest concentrations are
in the liver. Cytochromes P450 are membrane bound and located in the ER.
In its oxidised form cytochrome binds the substrate; Fe3+ is reduced to Fe2+ which
then binds oxygen. The reaction cycle is shown in Figure 1.5 (page 22). To complete
this cycle a cytochrome P450 reductase is needed (Reichl, 2009; Uetrecht & Trager,
2007).
WormBase lists 81 C. elegans genes in the cyp gene class (WormBase, 29/04/2010).
Menzel et al. (2001, 2005) studied the effects of a range of cytochrome P450 induc-
ers, including benzo[a]pyrene, benzene, rifampicin, and phenobarbital, using mRNA
expression. They found that the subfamilies CYP35A, 35C, 31A, and 29A were most
inducible.
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Figure 1.5: The P450 reaction cycle. (The University of Scranton, n.d.)
Short chain dehydrogenases/reductases (SDRs)
Short chain dehydrogenases/reductases can be found in the smooth ER and in the
cytosol. They catalyse the reduction of carbonyl groups in aldehydes and ketones.
In C. elegans SDRs are encoded by the dhs gene class which comprises 30 genes (Worm-
Base, 29/04/2010).
1.3.2 Phase II metabolism
Phase II metabolism is the actual detoxification of xenobiotics. The major aim is to
prepare them for elimination from the body via the urine or in C. elegans most probably
via the gut and defecation.
Glutathione S-transferases (GSTs)
The tripeptide glutathione (GSH) is a protective compound required for the removal
of potentially toxic electrophilic compounds. This is particularly important, as many
drugs are metabolised to strong electrophiles by phase I metabolism. The compounds
are conjugated to GSH by glutathione S-transferases (GSTs). Substrates include var-
ious drugs, carcinogens, and pesticides. They are generally hydrophobic and elec-
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trophilic and react non-enzymatically with the nucleophilic GSH to a certain extent.
The induction of GSTs is an evolutionarily conserved response to oxidative stress in an-
imal and plant kingdoms. There are three classes in humans: cytosolic, mitochondrial
and microsomal GSTs. They are mainly found in liver, kidney, gut, testis, and adrenal
glands. GSTs undergo induction by certain xenobiotics, e.g. 3-methylcholanthrene or
TCDD and by the inorganic heavy metal Pb (Gibson & Skett, 1994; Hayes et al., 2005;
Timbrell, 2000).
In C. elegans 44 gst genes have been identified that encode GST proteins (WormBase,
29/04/2010). gst genes are upregulated in C. elegans following exposure to e.g. acry-
lamide (Hasegawa et al., 2008). They also play a role in the protection against reactive
oxygen species (ROS). gst-p24 is upregulated following exposure to ROS-generating
chemicals (Leiers et al., 2003).
Metallothioneins
Metallothioneins are a family of relatively small, cysteine-rich proteins that have the
ability to bind heavy metals. They are involved in the transport of metals such as zinc
in the body. Other metals, e.g. cadmium, may also bind to metallothioneins. A chronic
increase in cadmium concentrations induces metallothionein expression. The protein
therefore has a protective function (Timbrell, 2000).
In C. elegans there are two metallothionein genes (mtl). In addition to metal detoxifica-
tion and homeostasis they function in stress adaptation, regulating growth and fertility.
Their expression is also induced after exposure to heat (WormBase, 29/04/2010).
Heat shock proteins (HSPs)
The expression of heat shock proteins (HSPs) is increased when cells are exposed to
elevated temperatures or other stresses. These could include infection or inflammation
or exposure of the cell to toxins such as ethanol and trace metals. UV light, starvation,
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hypoxia, or water deprivation can also increase hsp gene expression. HSPs are divided
into different families according to their size (Santoro, 2000).
WormBase lists more than 20 C. elegans genes in the hsp gene class (WormBase,
29/04/2010).
1.4 Furan
1.4.1 Chemical and physical properties
Furan (also known as furane or furfuran, divinylene oxide, oxacyclopentadiene, or oxole)
has the chemical formula C4H4O, a molecular weight (MW) of 68.08 g/mol and a density
of 0.936 g/ml. It is a toxic organic compound. The chemical structure of furan is shown
in Figure 1.6. Furan is a clear, colourless liquid with a characteristic odour which turns
brown upon standing. The melting/freezing point of furan is at -85.6 ◦C and its boiling
point at 31.3 ◦C. Thus, furan quickly vaporises and is highly flammable. Its solubility
in water is only 1 %, but it is miscible with ethanol.
Figure 1.6: Chemical structure of furan. (own illustration)
Furan is irritating to the skin and eyes and must therefore be handled with care (Po-
hanish, 2002).
1.4.2 Occurrence and use of furan
Furan is ususally used in industry where it is both a solvent and an intermediate in the
production of nylon, resins, lacquers, insecticides, or pharmaceuticals. It has also been
found in a variety of foods, mainly those that undergo heat treatment such as bread,
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coffee, tinned and bottled food including sauces, soups, meat, fish, canned fruit and
vegetables, and baby food (Jestoi et al., 2009; U.S. Food and Drug Administration,
2004). It is therefore one of the so called ”food borne toxicants”. Concentrations are
especially high when food is heated in a closed system. The furan that is generated
cannot leave the system and stays in the food (Kuballa, 2007). Smog and cigarette
smoke also contain furan. As furan was found to be carcinogenic (Section 1.4.3), its
occurrence in food has been a concern for several years now. Research is ongoing in
order to determine the danger of furan in food and to find out more about its metabolism
in the human body.
1.4.2.1 Mechanisms of furan formation in food
Several mechanisms have been proposed which explain the formation of furan in food
(Crews & Castle, 2007; Vranova´ & Ciesarova´, 2009; Yaylayan, 2006). The first one
is the formation of furan from carbohydrates, also called the ”Maillard reaction”.
This is also the main reaction responsible for the browning of foods (caramelisation).
The carbohydrates react with amino acids in an aldol condensation reaction and the
resulting aldotreose intermediate then undergoes cyclisation to form furan. A second
mechanism is the formation of furan from polyunsaturated fatty acids (PUFAs)
and carotenoids. This process involves lipid oxidation of PUFAs and the formation of
lipid peroxides. Homolytic cleavage results in the formation of highly toxic 2-alkenals
which are converted to furan by cyclisation and subsequent dehydration. The third
mechanism is furan formation from ascorbic acids (vitamin C). Different pathways
have been proposed depending on the reaction conditions. As ascorbic acid produces
acetaldehyde and glycolaldehyde upon heating, furan can be produced through aldol
condensation. In addition, similar to carbohydrate degradation, four carbon precursors
could be formed and subsequently converted into furan. Furan generation from ascorbic
acids is dependent on the reaction conditions (e.g. headspace, amount of starch present)
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and seems to be less efficient than the generation from PUFAs (Owczarek-Fendor et al.,
2010). A summary of the proposed mechanisms of furan generation is shown in Figure
1.7.
Figure 1.7: Proposed mechanisms of furan generation. Furan is generated from car-
bohydrates, polyunsaturated fatty acids, or via aldol condensation (Vranova´ &
Ciesarova´, 2009).
1.4.2.2 Detection and quantification of furan in food
There are two approaches for the detection of furan in food samples. The first is
based on direct headspace-gas chromatography/mass spectrometry (GC/MS). Due to
the high volatility of furan, this is the obvious method. Samples are usually chilled
at ∼4 ◦C and homogenised. Sufficient cold water must be present for the the sample
to be mobile. Partitioning of furan from the sample into the headspace is affected by
time, temperature, and the mobility of the sample. For headspace analysis the samples
are usually heated. However, for furan this is unnecessary. Also for some samples it
might cause the formation of additional furan. The second method that was developed
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for furan detection is based on solid phase microextraction-GC/MS (SPME-GC/MS),
which is more sensitive. In both procedures furan is identified by GC, looking at the
retention time and the correct ratio of the molecular ion at m/z 68 to the fragment
ion at m/z 39. Quantification can be done by adding a deuterium-labelled internal
standard (Crews & Castle, 2007; Yaylayan, 2006).
1.4.3 Furan toxicity and carcinogenesis
Furan is hepatotoxic and hepatocarcinogenic both in vitro and in vivo. It can induce
cytolethality in freshly isolated F-334 rat hepatocytes in suspension. This effect is dose-
and time-dependent (Carfagna et al., 1993). In vivo studies have shown that furan is
a rodent carcinogen. In a 2-year bioassay in F344 rats, furan induced liver tumors and
cholangiocarcinomas (cancer of the bile ducts) (Burka et al., 1991).
The National Toxicology Program (NTP) conducted several studies on furan toxicity
and carcinogenesis in 1993. Doses up to 160 mg/kg body weight furan in corn oil were
given by gavage to F344/N rats and B6C3F1 mice of each sex for 16 days, 13 weeks
and 2 years. After 16 days, mottled and enlarged livers were observed at necropsy in
rats that were given 20-160 mg/kg. Mortality was increased in both species. After
13 weeks, increased liver weights were observed in all mice and rats that were given
furan. There was also an increase in kidney weights in female rats and a decrease in
thymus weights in all rats. Toxic lesions of the liver could be seen in all rats and mice
that received furan and these lesions increased with dose. Rats that received 30 or
60 mg/kg showed kidney lesions; mice that received the same doses showed bile duct
hyperplasia and cholangiofibrosis. Rats that received 60 mg/kg showed thymic atrophy
and testicular or ovarian atrophy. After two years during which rats were given 2, 4, or
8 mg/kg five days per week, hepatocellular adenomas or carcinomas were significantly
increased. The incidence of non-neoplastic liver lesions was also increased. Survival
was significantly decreased in rats that received 8 mg/kg. Mice dosed with 8 or 15
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mg/kg five days per week over two years showed decreased survival and various non-
neoplastic hepatocellular lesions as well as an increase in hepatocellular adenomas and
carcinomas (National Toxicology Program, 1993).
In a comprehensive study over three months, male Sprague Dawley rats were given daily
doses of furan by gavage. They developed liver changes as early as 8 hours after dosage.
Histological and immunocytochemical investigations revealed that repair processes fol-
lowing early liver injury caused by furan eventually led to cholangiofibrosis (Hickling
et al., 2010).
Since 1995 furan has been classified as ”possibly carcinogenic to humans (Group 2B)” (In-
ternational Agency for Research on Cancer (IARC), 1995).
Only recently it was found that subchronic furan treatment has an impact on the repro-
ductive system of the male rat. Rats that were given 2, 4, and 8 mg furan/kg bwt daily
over 90 days were examined. The number of red blood cells, thrombocyte numbers
and hemoglobin concentrations were increased. No differences in sperm counts were
observed, but furan caused apoptosis in germ cells and Leydig cells, impaired spermato-
genesis and decreased luteinising hormone (LH) and testosterone levels (Karacaogˇlu &
Selmanogˇlu, 2010).
The highest level of furan in food was 6.9 mg/kg, detected in roasted ground coffee (Eu-
ropean Food Safety Authority, 2010). It is therefore worth noting that the lowest tested
dose in all these studies was 2 mg/kg bwt per day. For an adult of 60 kg, this would
be equal to 20.7 kg ground coffee per day. Mean levels of furan in coffee were generally
less than 100 µg/kg.
Mechanism of furan toxicity
The mechanisms of furan toxicity are still unknown. Studies have yielded different
results as to whether or not it shows genotoxic activity.
28
Reynolds et al. (1987) found a different pattern of mutations in H-ras genes of furan
treated animals from the one observed in untreated controls, even though the overall
frequency was similar. Spontaneous mutations occurred at codon 61 which resulted in
activation of H-ras genes, whereas 60 % of the furan-induced mutations were either
in K-ras genes or at positions other than codon 61. They concluded that there were
genotoxic effects of furan, as they could not find cytotoxic effects that would have
suggested an alternative mechanism. Unfortunately, it is unclear what doses caused
the effects described in this study. Johansson et al. (1997) reached a similar result.
They reported an increased incidence and multiplicity of liver tumors in B6C3F1 mice
treated with six doses of 200 mg/kg bwt furan. They also found a numerical but not
statistically significant increase in tumor incidence and multiplicity following a single
dose of 400 mg/kg bwt furan. Interestingly, they report an 82 % relative activation
frequency of Hras1 in tumors from the 400 mg/kg bwt group but only a 32 % relative
activation frequency in the 6 x 200 mg/kg bwt group. These findings suggest that there
may be a different mechanism of tumor induction at low and high doses. The authors
conclude that the induction of liver tumors by furan is at least partially attributable
to a genotoxic mode of action.
Furan induced trifluorothymidine (TFT) resistance in mouse lymphoma cells. Fur-
thermore, higher frequencies of sister chromatid exchanges (SCE) and chromosomal
aberrations were observed in bone marrow cells of male B6C3F1 mice treated with
furan compared to controls. The same was found in Chinese hamster ovary (CHO)
cells (National Toxicology Program, 1993). These results are also indicative of geno-
toxicity.
Other NTP experiments of the 1993 study, however, did not indicate genotoxicity. Fu-
ran was tested for mutagenicity in Salmonella typhimurium (strains TA100, TA1535,
TA1537, and TA98 with and without induced S9). Concentrations up to 10,000 µg/plate
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were tested. None of the strains showed any mutagenic activity. The sex-linked recessive
lethal (SLRL) test in male Drosophila also failed to show any increase in mutations af-
ter administration of furan in feed or by injection (National Toxicology Program, 1993).
These results correspond with the findings of Burka et al. (1991). They studied male
rats in a 2-year bioassay with [14C]furan and found an increase in cholangiocarcino-
mas. After showing that most of the furan-derived radioactivity could be found in the
liver, they could not detect any binding of furan to DNA. Furan metabolites could be
found in the urine, therefore it was suspected that furan is metabolised in the liver with
reactive intermediates binding to protein. These metabolites may also be responsible
for carcinogenesis. Using a flow cytometer-based micronucleus assay looking at mouse
erythrocytes and human lymphocytes, Durling et al. (2007) also found no evidence of
genotoxicity in vivo or in vitro. In studies over three weeks and two years Moser et al.
(2009) could show that furan induces hepatic cytotoxicity and compensatory cell prolif-
eration in mice. A threshold of 4.0 mg furan/kg bwt for furan-induced liver tumors was
found. Lower doses did not induce hepatocarcinogenesis. Again, these results indicate
that furan is not genotoxic.
Pre-treatment of cells with the cytochrome P450 ligand and inhibitor 1-phenyl-imidazole
inhibited furan-induced cytolethality and GSH-depletion in vitro and prevented in-
creases in state 4 respiration and ATPase activity caused by furan in F-344 rats (Carfagna
et al., 1993; Mugford et al., 1997). In contrast cytolethality and GSH-depletion were
amplified by pre-treatment of rats with acetone, which induces cytochrome P450 2E1
(Carfagna et al., 1993). Furan biotransformation in F-344 rats could be inhibited by
pre-treatment with aminobenzotriazole, which is an inhibitor of cytochromes P450 (Ked-
deris et al., 1993). These results suggest that cytochrome P450 is required for furan
metabolism and that it is a metabolite that causes toxicity.
Peterson et al. (2006) conducted LC/MS/MS experiments on the urine of rats treated
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with radioactively labeled furan. They detected the monoGSH conjugate of cis-2-
butene-1,4-dial (Figure 1.8). This indicates that furan is mainly metabolised to cis-
2-butene-1,4-dial which in turn undergoes GSH conjugation. It is suspected that the
genotoxic effects shown by some studies were also induced by cis-2-butene-1,4-dial and
not by furan itself (Durling et al., 2007; Fransson-Steen et al., 1997).
Figure 1.8: Chemical structure of Cis-2-butene-1,4-dial. (own illustration)
Peterson et al. (2000) found that cis-2-butene-1,4-dial is mutagenic in the Ames assay
in Salmonella typhimurium TA104 but not in TA97, TA98, TA100, and TA102. These
results indicate that cis-2-butene-1,4-dial induces specific mutations in bacteria and
could therefore be an important genotoxic and toxic intermediate in furan-induced
hepatocarcinogenicity. Byrns et al. (2006) developed an assay for the detection of
cis-2-butene-1,4-dial-derived DNA adducts. They discovered that cis-2-butene-1,4-dial
forms adducts with deoxycytidine (dCyd), deoxyadenosine (dAdo) and deoxyguanosine
(dGuo) in vitro. They also detected dCyd and dAdo adducts in isolated DNA from
S. typhimurium TA104 treated with cis-2-butene-1,4-dial.
Kellert et al. (2008) looked at the effect of cis-2-butene-1,4-dial on L5178Y tk+/− mouse
lymphoma cells. They report an increase in DNA migration in the comet assay and an
increase in the frequency of mutants in the mouse lymphoma tk+/− assay. However,
they did not find any effect of furan in the micronucleus assay.
The discussion about the possible genotoxicity of furan is ongoing and the results remain
inconclusive. Nevertheless, it seems likely that furan is metabolised by a cytochrome
P450 in the liver with cis-2-butene-1,4-dial as the main metabolite, which appears to
be responsible for the toxic effects seen in some studies.
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1.4.4 Risk assessment
Assuming a NOAEL of 2 mg/kg bwt per day, Kuballa (2007) applied a safety factor
of 1000. The ADI would therefore be 2 µg/kg bwt. For the average adult with 60
kg body weight, this means an ADI of 120 µg. The European Food Safety Authority
(2010) reports the analysis of 1322 baby food samples between 2004 and 2009, detecting
concentrations up to 224 µg/kg. Assuming an intake of commercial baby food in glass
jars of 234 g food per day, this would lead to an exposure of up to 52 µg furan per day.
Given that a baby has a relatively small body weight and jarred baby food might be
the only diet for many infants, the acceptable daily intake would be reached easily.
For risk assessment purposes it is very important to know what mechanisms of action are
involved in furan carcinogenesis. Non-genotoxic carcinogens usually activate receptors.
Receptor activation follows non-linear kinetics, thus the dose response relationship has
a no effect level. This means that below a certain threshold no effect can be seen
(NOAEL). In contrast, genotoxic carcinogens cause cancer even in very low doses. One
single DNA adduct may theoretically lead to a mutation that causes cancer. Figure 1.9
(page 33) shows the dose response curves for two different toxicants.
1.5 Aims of the project
The fact that the mechanism of furan toxicity and carcinogenesis is still unknown
warrants further research into the problem. The aim of this project is to contribute to
the understanding of furan toxicity. This is important as it might have implications
on risk assessment. Current experiments described in the literature concentrate on the
effects of furan in mice and rats or in vitro studies. The use of C. elegans molecular
biology is a novel approach to the problem. As major pathways and mechanisms are
often highly conserved between species, this could give further insight into the toxicity
32
Figure 1.9: Comparison of the dose-response relationships for two different toxicants
A and B. For toxicant B there is a response at any dose with no threshold. For
toxicant A there is a threshold level below which there is ”no observed adverse
effect” (NOAEL). For compounds such as B there is no safe dose. (own illustration)
of furan. The following approaches were chosen to characterise the mode of action of
furan in C. elegans:
• Furan inhibits growth, reduces brood size and increases lethality in C. elegans
(Budd, 2008). In earlier projects EMS-derived mutants had been isolated that
were apparently resistant to furan (Cai, 2009).
The first aim of this project is to identify the gene affected. This is approached
by selecting furan resistant mutants in a brood size assay. The next step is to
map the mutation to a relatively small area of the genome using SNP mapping
techniques and subsequent whole genome sequencing.
• Toxicity assays are used to characterise the effect of different furan concentrations
on growth and feeding.
• Changes in the expression of several genes known to be involved in C. elegans
stress response are monitored using GFP reporter strains.
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2 Materials and Methods
2.1 Chemicals
The hazard and risk assessments of all substances used in my work were read and
understood in advance of carrying out the work and the recommended precautions
were adhered to.
Table 2.1 lists all chemicals that were used in these experiments.
Table 2.1: List of chemicals and suppliers
Chemical CAS-No. Supplier
Agar n/a Melford Laboratory Ltd.
CaCl2 10043-52-4 Sigma-Aldrich
Cholesterol 57-88-5 Sigma-Aldrich
Citric acid (C6H8O7) 77-92-9 B.D.H. Ltd.
CuSO4 · 5 H2O 7758-99-8 Fisher Scientific UK Ltd.
Ethanol absolut (C2H5OH) 64-17-5 Sigma-Aldrich
FeSO4 · 7 H2O 7782-63-0 Sigma-Aldrich
Furan C4H4O 111-00-9 Sigma-Aldrich
Glycerol C3H5(OH)3 56-81-5 Duchefa Farma B.V.
KCl 7447-40-7 B.D.H. Ltd.
KH2PO4 7778-77-0 Fisher Scientific UK Ltd.
Continued on next page
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Table 2.1 – continued from previous page
Chemical CAS-No. Supplier
K2HPO4 7758-11-4 Fisher Scientific UK Ltd.
LB Agar n/a Melford Laboratory Ltd.
LB Broth n/a Melford Laboratory Ltd.
MgSO4 1003-99-8 Fisher Scientific UK Ltd.
MnCl2 · 4 H2O 13446-34-9 Sigma-Aldrich
NaCl 7647-14-5 Fisher Scientific UK Ltd.
Na2EDTA 139-33-3 Sigma-Aldrich
NaOCl 7681-52-9 Sigma-Aldrich
NaOH 1310-73-2 Fisher Scientific UK Ltd.
Peptone n/a Sigma-Aldrich
Potassium citrate (C6H5K3O7) 866-84-2 Fisher Scientific UK Ltd.
Sodium azide (NaN3) 26628-22-8 Sigma-Aldrich
Sucrose (C12H22O11) 57-50-1 Fisher Scientific UK Ltd.
Tryptone n/a Melford Laboratory Ltd.
Yeast extract n/a Melford Laboratory Ltd.
ZnCl2 7646-85-7 Sigma-Aldrich
ZnSO4 · 7 H2O 7446-20-0 Sigma-Aldrich
2.2 Buffers and Media
Solutions were made up to 1 l with UHP water, autoclaved, and stored at room tem-
perature unless otherwise stated.
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Citrate buffer (1 M, pH 6.0)
1 M citric acid
1 M potassium citrate
500 ml of citric acid and potassium citrate were prepared and autoclaved. The citric
acid was then titrated with potassium citrate until pH 6.0 was reached.
Egg isolation bleach solution
6 ml 1 M NaOCl (available chlorine 10-15 %, stored at 4 ◦C)
12 ml 10 M NaOH
30 ml H2O
The NaOCl should not be older than 6 months to prevent degradation. The bleach
solution can be stored at 4 ◦C for several weeks.
Freezing Down Solution
300 g/l Glycerol
5.85 g/l NaCl
50 mM Potassium phosphate buffer (pH 6.0)
After autoclaving, MgSO4 was added to a final concentration of 0.3 mM. Storage was
at 4 ◦C.
K-Medium
32 mM KCl
53 mM NaCl
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Luria Bertani (LB) agar
10 g/l NaCl
5 g/l Tryptone
5 g/l Yeast Extract
17 g/l Agar
LB agar was bought as a ready-made mix from Melford Laboratory Ltd. and made up
according to the manufacturers instructions.
Luria Bertani (LB) broth
10 g/l NaCl
10 g/l Tryptone
5 g/l Yeast Extract
LB broth was bought as a ready-made mix from Melford Laboratory Ltd. and made
up according to the manufacturers instructions.
Nematode Growth medium (NGM) agar
3 g/l NaCl
17 g/l Agar
2.5 g/l Peptone
5 mg/l Cholesterol
Cholesterol was prepared as a 5 mg/ml stock in ethanol and kept at 4 ◦C. The stock
solution was added before autoclaving. After autoclaving the NGM agar was allowed
to cool to 60 ◦C. The following solutions were heated to 60 ◦C in a water bath and
added to the agar to give a final concentration of:
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1 mM CaCl2
1 mM MgSO4
40 mM Potassium phosphate buffer (pH 6.0)
Potassium phosphate buffer (pH 6.0)
1 M KH2PO4
1 M K2HPO4
1 M KH2PO4 was titrated with 1 M K2HPO4 until pH 6.0 was reached.
S-Basal
5.84 g/l NaCl
50 mM Potassium phosphate buffer (pH 6.0)
S-Medium
The following substances were added to S-Basal to get S-Medium:
10 ml/l Cholesterol
2 mM Citrate buffer (pH 6.0)
0.3 mM CaCl2
0.3 mM MgSO4
0.05 % Trace metal solution
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Trace Metal Solution
2.5 mM FeSO4 · 7 H2O
5 mM Na2EDTA
1 mM MnCl2 · 4 H2O
1 mM ZnSO4 · 7 H2O
0.1 mM CuSO4 · 5 H2O
The trace metal solution was stored in the dark.
2.3 C. elegans - General methods
The reference Bristol N2 strain was used in previous studies to generate furan resistant
mutants of C. elegans (Cai, 2009). Mutant stocks had been frozen and were used in
these experiments for further analysis. They were labeled 8R1, 13R1, 13R2, 16R2, and
16R6. CB1480 him-7 and CB1467 him-5 strains that show 3 % and 20 % male (XO) self-
progeny respectively, were used in additional experiments (WormBase, 29/04/2010).
C. elegans were kept on Nematode Growth Medium (NGM) agar plates with E. coli
OP50. They were handled according to established protocols (Stiernagle, 1999). Worms
were usually kept at 15 ◦C until otherwise stated.
2.3.1 Microscopy of C. elegans
C. elegans were looked at under a Wild M3 stereo microscope at 6.4x, 16x and 40x
magnification. Worms from the L1 growth assay were imaged on microscope slides using
a Zeiss Axiovert 135TV microscope at 20x magnification, and photographed using a
Scion 1310M CCD camera and the MicroManager 1.3 software. The worm images were
saved as .tif files and processed in Adobe Photoshop CS3.
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Preparation of agarose pads
For the agarose pads, a 2 % (w/v) agarose solution was used. Figure 2.1 illustrates
the preparation process. Tape was stuck lengthwise along two slides. This provided
a spacer for the agarose pad. A clean slide was placed between the two taped slides.
Two drops of melted agarose were placed on the slide and another slide was quickly
placed on top at right angles. After a few minutes the agarose was set. The top slide
was removed immediately before using the pad in order to prevent the agarose from
drying out.
Figure 2.1: Preparation of agarose pads on microscope slides (Hyman, 2010).
2.3.2 Preparation of agar plates
NGM agar was prepared as explained in Section 2.2. The following steps were carried
out under a class II hood:
For 3 cm plates, exactly 4 ml of agar was poured into each plate with a syringe. 9 cm
and 14 cm plates were poured by hand. The plates were left to dry and E. coli culture
was added. E. coli OP50 is dependent on uracil, which results in a thin bacterial lawn
on the plates. This is important to enable C. elegans movement. After drying, the
plates were incubated overnight at 37 ◦C and then kept in a closed plastic container at
room temperature until use.
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2.3.3 Transfer of worms
A wormpick was used to transfer single worms from one plate to another. A wormpick
is a small piece of platinum wire sealed to a glass pasteur pipette. When plates were
almost starved, worms were transferred to new plates by “chunking”: a small piece of
agar was cut out with a sterile scalpel and transferred to a new plate. To transfer all
worms from one plate, e.g. to a centrifuge tube, worms were washed off with several
millilitres of K-Medium or S-Basal and transferred with a pipette.
2.3.4 Egg isolation
The isolation of eggs from a plate is referred to as ”bleaching”. It is done to synchronise
cultures, and to remove contamination such as mould or bacteria other than E. coli.
For synchronisation, 3 cm plates containing mostly gravid adult worms were used. The
worms were washed off the plate with 2 ml S-Basal and 3 x 0.5 ml were transferred to
three 1.5 ml Eppendorf tubes. The same amount of bleach solution was added and the
tubes were immediately vortexed for three minutes. The tubes were then centrifuged
for two minutes at 500 g and 4 ◦C. The supernatant was discarded and the pellets
were each washed with 1 ml of S-Basal. Centrifugation and washing were repeated
three times. The pellets were then resuspended in 3 x 0.5 ml of S-Basal. The eggs
were transferred to a six well plate (0.5 ml per well) which was sealed with parafilm
and incubated at 15 ◦C over night to allow L1 worms to hatch. The worms were then
transferred to fresh 3 cm NGM plates containing E. coli OP50 with a pipette.
2.3.5 Freezing and Thawing
Worm stocks were frozen at -80 ◦C for future use. To prepare worms for freezing,
an egg isolation was done and the L1 worms were transferred to a bacteria-free 9 cm
plate. The plate was incubated at 20 ◦C until the worms were starved. They were then
washed off with 3 ml K-medium. The K-Medium was transferred to a 15 ml tube and
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3 ml of freezing down solution were added. The tube was vortexed and 1 ml aliquots
were transferred to Eppendorf tubes. The tubes were labelled with the name of the
strain and the date and stored at -80 ◦C.
To check if freezing was successful one aliquot was thawed at room temperature the
next day and the contents transferred to a 9 cm agar plate containing E. coli OP50.
The plate was incubated at 20 ◦C over night to see if worms were alive.
2.3.6 C. elegans liquid culture
• Single colonies of E. coli OP50 were incubated in 5 ml LB medium at 240 rpm,
37 ◦C overnight.
• 5 ml of OP50 overnight culture were added to 500 ml of LB medium in a 1 l flask
and incubated in a shaking incubator at 240 rpm, 37 ◦C overnight.
• 500 ml OP50 overnight culture were decanted into two 500 ml centrifuge bottles
and centrifuged at 11,000 g for 20 minutes.
• The pellet was resuspended in K-Medium and diluted to a OD600 of 1.5-1.7. The
OD was measured in a Cecil Instruments Super Aquarius CE 9500 spectropho-
tometer.
• A 14 cm plate of starved worms was washed off with K-Medium.
• The worms were left on ice for 30 minutes to settle and the supernatant was
discarded. The worms were then resuspended in 10 ml of K-Medium. This
washing was repeated three times.
• The worms were then added to 500 ml of the bacterial culture in a 1 l flask.
• The liquid culture was incubated at 20 ◦C in a shaking incubator at 240 rpm for
5-6 days.
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2.3.7 Synchronising liquid cultures
• The liquid culture containing large numbers of gravid adults was set on ice for 30
minutes for the worms to settle.
• The supernatant was removed until about 100 ml were left. The remaining liquid
containing the adult worms was transferred to two 50 ml centrifuge tubes and set
on ice again for 30 minutes.
• As much of the supernatant as possible was removed.
• An equal amount of bleach solution was added to the remaining liquid.
• The tubes were immediately vortexed for five minutes. The tubes were then
centrifuged for two minutes at 500 g and 4 ◦C. The supernatant was discarded and
the pellet was washed with S-Basal. Centrifugation and washing were repeated
three times. The pellet was then resuspended in S-Basal.
• The isolated eggs were transferred to six well plates (1 ml per well) which were
sealed with parafilm and incubated at 15 ◦C overnight to allow L1 worms to
hatch. The worms were then transferred to fresh NGM plates with a pipette.
2.4 Toxicity Assays
Appropriate precautions were observed when handling furan.
2.4.1 Furan brood size assay
Because of the low solubility of furan in water, the assay was initially set up using stock
solutions of furan in 100 % ethanol (Table 2.2, page 44). The assay ran over eight days:
• Day 1: 3 cm plates containing adult worms were bleached as described in section
2.3.4.
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Table 2.2: Furan stock solutions in ethanol.
Stock concentration Furan Ethanol
200 mM 14.5 µl 985.5 µl
400 mM 29 µl 971 µl
800 mM 58 µl 942 µl
2,000 mM 145.4 µl 854.6 µl
4,000 mM 290.8 µl 709.2 µl
8,000 mM 581.6 µl 418.4 µl
12,000 mM 872.4 µl 127.6 µl
• Day 2: L1 worms were transferred to 3 cm NGM plates and incubated at 15 ◦C
for three days.
• Day 5: 10 ml of E. coli OP50 liquid culture were centrifuged at 2,000 g for five
minutes. The supernatant was discarded and the pellet resuspended in 10 ml
S-Basal. The absorbance was adjusted to OD600 0.7 against S-Basal. The assay
was then set up in 48 well plates. Concentrations were tested in triplicate. Each
well contained 40 µl of bacterial culture, a single L4 worm, toxin and S-Basal
to a final volume of 400 µl (Table 2.3). The toxin was added last to prevent
evaporation.
Table 2.3: Furan brood size assay with furan dissolved in ethanol. This is the initial protocol
as carried out by Cai (2009).
Furan OP50 L4
worms
S-Basal Furan stock solu-
tion
0 mM 40 µl 1 359 µl 1 µl of ethanol
0.5 mM 40 µl 1 359 µl 1 µl of 200 mM
1 mM 40 µl 1 359 µl 1 µl of 400 mM
2 mM 40 µl 1 359 µl 1 µl of 800 mM
5 mM 40 µl 1 359 µl 1 µl of 2,000 mM
10 mM 40 µl 1 359 µl 1 µl of 4,000 mM
20 mM 40 µl 1 359 µl 1 µl of 8,000 mM
30 mM 40 µl 1 359 µl 1 µl of 12,000 mM
The plates were immediately sealed with two layers of parafilm and placed in a
plastic container together with a damp paper towel to provide humidity. The
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plates were incubated at 15 ◦C for three days.
• Day 8: The number of progeny in each well was counted. Note that this is only
a partial brood size.
The concentrated furan solutions were found to dissolve the pipette tips. Therefore,
tenfold dilutions of all stocks were prepared in S-Basal and 350 µl S-Basal plus 10 µl
of the diluted stocks were used in the assay. This also improved the accuracy, as 1 µl is
very hard to pipette. However, the results of the brood size assay were very inconsistent,
so changes to the protocol were made to reduce variability.
As up to 1 % furan is soluble in water it was decided not to dissolve it in ethanol. This
should reduce the confounding effects caused by chemicals other than furan. It also
allowed higher concentrations of furan to be tested. The incubation time was extended
to four days, because the offspring were very tiny and hard to count after three days.
The modified assay was set up over nine days:
• Day 1: 3 cm plates containing adult worms were bleached as described in section
2.3.4.
• Day 2: L1 worms were transferred to 3 cm NGM plates and incubated at 15 ◦C
for three days.
• Day 5: 50 ml of bacterial culture were centrifuged at 2,000 g for five minutes.
The supernatant was discarded and the pellet resuspended in 50 ml S-Basal. The
absorbance was adjusted to OD600 0.7 against S-Basal. The assay was then set
up in a 48 well plate. Concentrations of 0, 10, 30, 60, and 90 mM furan were
tested and each concentration was tested in triplicate. Each well contained 40 µl
of bacterial culture, a single L4 worm, toxin and S-Basal to a final volume of
400 µl. The furan was dissolved in S-Basal (65.4 µl in 9 ml) and vortexed for
45
three minutes. It was added last to prevent evaporation (Table 2.4). The plates
were sealed and incubated in a plastic box with damp paper towels at 15 ◦C for
four days.
Table 2.4: Modified furan brood size assay without ethanol. 65.4 µl of furan were dissolved
in 9 ml of S-Basal to give the furan solution used in this experiment.
Furan OP50 L4 worms S-Basal Furan so-
lution
0 mM 40 µl 1 360 µl —
10 mM 40 µl 1 320 µl 40 µl
30 mM 40 µl 1 240 µl 120 µl
60 mM 40 µl 1 120 µl 240 µl
90 mM 40 µl 1 — 360 µl
• Day 9: The number of progeny in each well was counted. Again this was only a
partial brood size.
2.4.2 L1 growth assay
The L1 growth assay measures the effect of furan on C. elegans growth and develop-
ment. It is set up and run over five days.
• Day 1: 5 ml of LB broth were inoculated with a single colony of E. coli OP50
and incubated over night at 37 ◦C, 240 rpm. A plate of gravid hermaphrodite
worms was bleached as described in Section 2.3.4.
• Day 2: 1 ml of the bacterial culture was centrifuged for five minutes at 2,000 g.
The supernatant was discarded and the pellet resuspended in S-Basal.
• L1 worms were centrifuged for one minute at 500 g. The supernatant was dis-
carded and the worms were resuspended in S-Basal to give a final concentration
of 30-40 worms per 5 µl.
• The OD600 of the bacterial culture was adjusted to 0.7 with S-Basal.
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• The assay was then set up in a 24 well plate with four wells for each concentration.
Each well contained 5 µl of L1 worms, 40 µl of E. coli OP50 solution, toxin and
S-Basal to a final volume of 400 µl. Again, the furan was dissolved in S-Basal
(58.2 µl in 9 ml) and vortexed for three minutes. It was added last to prevent
evaporation (Table 2.5).
Table 2.5: L1 growth assay. 58.2 µl of furan were dissolved in 9 ml of S-Basal to give the
furan solution used in this experiment.
Final
conc.
OP50 L1 worms S-Basal Furan so-
lution
0 mM 40 µl 5 µl 355 µl —
10 mM 40 µl 5 µl 310 µl 45 µl
30 mM 40 µl 5 µl 220 µl 135 µl
45 mM 40 µl 5 µl 152.5 µl 202.5 µl
60 mM 40 µl 5 µl 90 µl 270 µl
80 mM 40 µl 5 µl — 360 µl
• The plates were sealed and incubated in a plastic box with damp paper towels at
15 ◦C for three days.
• Day 5: 15 µl of 1 M sodium azide were added to each well to immobilise the
worms.
• The contents of each well were transferred to 1.5 ml centrifuge tubes. The lids of
the tubes were removed before so that the pellet is not disturbed and centrifuged
for one minute at 500 g. The supernatant was removed, leaving approximately
10-20 µl. The pellet was resuspended in the remaining liquid by briefly vortexing.
• Agarose pads were prepared as described in Section 2.3.1. Each slide was labelled
with a concentration.
• The worms were gently mixed and 10 µl were carefully pipetted onto the agarose
pads. A coverslip was placed on top.
• The worms were imaged under 20x magnification and photographed.
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• The worm size (area) was measured in pixels using Adobe Photoshop CS3 and
the magnetic lasso tool (Figure 2.2).
• The worm sizes at different concentrations were recorded as ”percent of control”.
Figure 2.2: Measurement of C. elegans size. The worms were imaged at 20x magnification,
photographed and their size (area) measured in Adobe Photoshop CS3 using the
magnetic lasso tool.
2.4.3 Furan feeding inhibition assay
For the feeding inhibition assay worms grown in liquid culture were used.
• The worms were set on ice for 30 minutes to settle down. Then the supernatant
was discarded and the worms washed with K-Medium. This washing procedure
was repeated several times to remove all bacteria.
• The worms were resuspended in a small volume of K-Medium, transferred to a
small beaker, and stirred.
• Six well plates were labelled with the concentrations.
• 50 µl of worms were added to each well. The worms were stirred during dispensing
to make sure equal numbers were added to each well.
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• 1,500 µl of E. coli OP50 (OD550 1.0) containing the furan were added to each well.
Table 2.6 shows the amount of furan dissolved per milliliter OP50 suspension for
this experiment. The solution was vortexed for three minutes before dispensing.
Table 2.6: Furan solutions used for feeding inhibition assay. The furan was dissolved
directly in OP50 suspension. This was done immediately before use to prevent
evaporation of the furan.
Final concentration
of furan
Volume furan per ml
bacterial suspension
10 mM 0.73 µl
20 mM 1.45 µl
30 mM 2.18 µl
45 mM 3.27 µl
60 mM 4.36 µl
90 mM 6.54 µl
• The plates were immediately covered with two layers of parafilm and incubated
in a plastic box for 24 hours at 15 ◦C.
• The next day the worms were transferred to Eppendorf tubes and left on ice for
30 minutes to settle.
• The OD of the supernatant was measured at 550 nm.
2.4.4 GFP reporter assay
In this assay GFP reporter strains of C. elegans were used to measure the expres-
sion levels of several genes involved in stress response pathways (de Pomerai et al.,
2010). The following strains were obtained from the Baillie Genome GFP Project
(Simon Fraser University, Burnaby, Vancouver, Canada) as integrated promoter::GFP
fusions: BC17553 (T09A12.2, designated GPA::GFP), BC20305 (C11E4.1, designated
GPB::GFP), BC-20306 (cyp-34A9::GFP), BC20308 (hsp-3::GFP), BC20316 (gst-1::GFP),
BC20330 (gst-4::GFP), BC20333 (sod-4::GFP), BC20334 (cyp-29A2::GFP), and BC20350
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(sod-1: :GFP). Thanks also to Cynthia Kenyon for CF1553 (sod-3::GFP), Chris Link
for CL2050 (hsp-16.2::GFP), Joel Rothman for JR2474 (cep-1::GFP), and Ralph Men-
zel for a strain with pPD97 87-35A2prIII-GFP (cyp-35A2::GFP). A description of the
genes and their functions can be found in Table 1.1 (page 17).
• Two 14 cm plates containing worms of all stages were washed off with K-Medium
and set on ice for 30 minutes to settle down. Then the supernatant was discarded
and the worms resuspended in K-Medium. This washing procedure was repeated
several times to remove all bacteria.
• The worms were resuspended in a small volume of K-Medium, transferred to a
small beaker, and stirred.
• 24 well plates were labelled with the concentrations. Individual plates were used
for different concentrations. Because of the high volatility of furan, individual
plates were also used for the measurements at different time points so the plates
did not have to be opened during the course of the experiment.
• 150 µl of worms were added to each well. The worms were stirred during dispens-
ing to make sure equal numbers were added to each well.
• 150 µl of 2x concentrated furan in K-Medium were added to each well. The furan
solutions were vortexed for three minutes before distribution. Because of the low
solubility of furan only concentrations up to 60 mM could be tested.
• The plates were covered with two layers of parafilm and incubated in a plastic
box at 15 ◦C.
• Measurements were taken after 4, 8, 16, and 24 hours in order to see early,
intermediate, and late induction. The contents of the wells were transferred to
black, non-fluorescent 96 well plates and the levels of GFP fluorescence measured.
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This was done in a Perkin-Elmer Victor 1420 plate fluorometer with the Wallac
1420 Manager software. Each well was measured four times for one second at
a time, using a ”F485” CW (continuous wave) excitation filter and a ”F535”
emission filter.
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2.5 Data presentation and statistics
All graphs and statistical analyses were done using GraphPad Prism 5.
Statistical analysis
Statistical analysis was carried out to determine if the difference between groups of
worms was statistically significant (P<α, α=0.05). The null hypothesis (H0) was that
there is no difference between the groups. If P<0.05, H0 was rejected and the difference
was statistically significant. If P>0.05, H0 could not be rejected.
For the brood size assay and the feeding inhibition assay, one-way ANOVA was used
which is based on several assumptions:
• The data must be from a population that is normally distributed (or approxi-
mately normally distributed).
• The samples must be independent.
• The variances of the samples must be equal. This was proven by Bartlett’s test
for equal variances.
Dunnett’s multiple comparison test was done to look at differences between group
means. This test compares groups against a reference. The null hypothesis is that no
group has a mean that is significantly different from the mean of the reference group.
For the brood size assay, all mutant strains and the two him strains were compared to
N2 wild type. For the feeding inhibition assay, the mean OD550 of the samples that
did not contain furan was used as reference.
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3 Results
3.1 Thawing of frozen mutant strains
Stocks of furan resistant mutant worms had been frozen and were thawed to identify the
mutation. The stocks were labelled 8R1, 13R1, 13R2, 16R2, and 16R6. Two aliquots
of 1 ml were available for each strain. Unfortunately, it was not possible to find out
which of these strains corresponded to the ”resistant lines” mentioned by Cai (2009).
Therefore, all strains were thawed and analysed. The aliquots were thawed at room
temperature and the contents of the tubes transferred to 9 cm agar plates containing
E. coli OP50. The plates were incubated at 20 ◦C over night.
As can be seen in Table 3.1, all stocks only contained very small numbers of worms
(<10 in each aliquot). The 13R1 stocks did not contain any living worms and no further
analyses could be done for this strain. The first aliquot of 16R6 worms only contained
one living worm. This was found to be male so the second aliquot had to be thawed as
well.
Table 3.1: Thawing of frozen mutant worms. This table shows the number of living worms
obtained from each frozen sample of 1 ml.
strain 1st aliquot 2nd aliquot
8R1 7 not thawed
13R1 0 0
13R2 4 not thawed
16R2 7 not thawed
16R6 1 2
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The strains 8R1, 13R2, 16R2, and 16R6 were grown on agar plates and tested for furan
resistance in the brood size assay.
3.2 Furan brood size assay
The brood size assay was done to identify furan resistant C. elegans mutants. The N2
wild type worms were expected to be sensitive to 30 mM furan (Cai, 2009) and should
not give any offspring. Furan resistant worms should give offspring in sublethal concen-
trations of furan. The experiment was also used to identify the selection concentration
(if different from 30 mM) to distinguish between resistant and non-resistant worms in
the following experiments.
In a 48 well plate single L4 worms were incubated in increasing concentrations of furan
for three days. After incubation, the number of offspring was counted. Initially the
brood size assay was done according to the method of Cai (2009). Only N2 wild type
worms were tested to see whether the assay was working. The furan was dissolved in
ethanol with final concentrations from 0 mM to 30 mM furan.
The results were inconsistent, highly variable and no reduction in brood size could be
seen (Figure 3.1, page 55).
3.2.1 Adjustment of experimental conditions
To locate possible errors, new N2 worms were taken from frozen stocks, all solutions
were freshly prepared, and a new bottle of furan was purchased. However, the results
could not be improved (data not shown).
Effect of temperature changes
The temperature of the incubator was found to be slightly too high (17 ◦C instead of
15 ◦C, data not shown) and varying within the incubator from 10.8 ◦C on the bottom
54
Figure 3.1: Results of furan brood size assay for N2 (mean and SD). Individual L4
worms were incubated in furan for four days and the number of offspring was
counted. Each concentration was tested in triplicate. This graph shows the re-
sult of a single experiment. Similar results were obtained in three independent
experiments.
shelf to 17.8 ◦C on the top shelf. Because higher temperatures might increase the
volatility of furan, the assay was incubated in a different incubator and a data logger
was put in the plastic box to monitor temperature changes. No significant difference
was seen between the two incubators (data not shown). Even though the results could
not be improved, the assay was from then on only incubated at the same place in the
new incubator to reduce variations in experimental conditions to a minimum.
Effect of ethanol as solvent for furan on C. elegans brood size
A literature research showed that ethanol, which was used as solvent for furan, has an
effect on movement and egg-laying in C. elegans (Davies et al., 2003, 2004). Ethanol
increases the activity of SLO-1 in neurons, which is a subunit of Ca2+-activated K+
channels (BK channels). As a result, SLO-1 inhibits neurotransmitter release which
causes the effect seen in C. elegans (Crowder, 2004). To eliminate the effects of ethanol
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on brood size, the furan was from then on dissolved directly in S-Basal.
The maximum solubility of furan in H2O is 1 % which allowed testing up to a final
concentrations of 90 mM. In addition, the incubation time was extended to four days
because the offspring were very small and hard to count in the 48 well plates after three
days.
Lethality
Again, a dose response experiment for N2 worms in increasing furan concentrations
(0-90 mM) was done. After four days, most of the adult worms were dead even at
concentrations lower than 30 mM (data not shown). This was surprising, as 30 mM
was used as selection concentration by (Cai, 2009) and was not considered to be lethal
to adult worms.
It was suspected that the reason for the lethality might be the high volatility of furan.
Different concentrations were subsequently incubated in individual 48 well plates to
prevent the furan from spreading to different wells and thus altering the concentration.
This approach considerably reduced the variability within the triplicates and increased
the survival of adult worms.
Final results
The results of the improved brood size assay are shown in Figure 3.2 (page 57). They
indicate that furan decreases the brood size of wild type C. elegans in a dose-dependent
manner. The brood size assay in its modified form gave robust and reproducible results.
To calculate the EC50, a sigmoidal curve was fitted plotting the log(agonist) vs. re-
sponse. In this case, the agonist was the furan concentration and the response was the
brood size. The EC50 for this experiment was 19.28 mM. 90 mM furan killed all adult
worms and no offspring were found in these wells. Concentrations lower than 90 mM
are considered sublethal. At 60 mM furan, N2 worms only gave very few offspring.
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Therefore, this concentration was chosen as selection concentration to test the frozen
mutant strains for furan resistance.
Figure 3.2: Results of furan brood size assay for N2 (mean and SD). Individual L4
worms were incubated in furan for four days and the number of offspring was
counted. Each concentration was tested in triplicate. This graph shows the results
of three independent experiments. Furan decreases C. elegans brood size in a dose-
dependent manner. The EC50 is 19.28 mM. 90 mM furan killed all adult worms and
therefore no offspring could be found. At 60 mM furan, N2 worms only gave 1-2
offspring. This concentrations was chosen as selection concentration for subsequent
experiments.
3.2.2 Comparison of mutant strains to wild type
To test the mutant strains for furan resistance, a brood size assay with the new condi-
tions was performed with worms from the frozen strains 8R1, 13R2, 16R2, and 16R6
and the number of offspring compared to N2. In addition, the two him-strains CB1467
and CB1480 were tested. This was done, because an increased incidence of males was
observed for the mutant strains in earlier experiments and it was suspected that the
mutation conferring resistance to furan might be in a him-gene (Cai, 2009). It was ex-
pected that at 60 mM furan, resistant worms would give significantly higher numbers
of offspring than N2 worms. The results of these assays are shown in Figures 3.3 and
57
3.4 (pages 58 and 60).
Furan resistance of strains 8R1, 16R2, and 16R6
As can be seen in Figure 3.3, the brood sizes of N2, 8R1, 16R2, and 16R6 without furan
are very similar. All brood sizes are clearly decreased at 60 mM. A one-way ANOVA
(α=0.05) was carried out to determine if any of the differences between the brood sizes
were statistically significant (P<α). Bartlett’s test for equal variances gave a P value
Figure 3.3: Results of furan brood size assay for strains N2 (control), 8R1, 16R2,
and 16R6 (mean and SD). L4 worms were incubated in furan for four days
and the number of offspring counted. Concentrations of 0 mM (left) and 60 mM
(right) were tested in triplicate. The graph shows the results of three individual
experiments.
of 0.3469, which shows that the variances of the samples are equal. Dunnett’s Multiple
Comparison Test showed that without furan, the mean brood size of 8R1, 16R2, and
16R6 are not significantly different from the mean brood size of N2 (Table 3.2, page
59).
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Table 3.2: Dunnett’s Multiple Comparison Test (GraphPad Prism 5). N2 worms without furan
were used as control group against which all other groups were compared.
N2 (0 mM furan) vs Mean Difference Significant?
P<0.05?
8R1 - 0 mM 4.000 No
16R2 - 0 mM 3.600 No
16R6 - 0 mM 1.800 No
N2 - 60 mM 17.00 Yes
8R1 - 60 mM 19.00 Yes
16R2 - 60 mM 18.80 Yes
16R6 - 60 mM 16.40 Yes
The brood sizes of N2, 8R1, 16R2 and 16R6 at 60 mM furan, however, are different
from the mean brood size of N2 without furan. This means that the reduction in brood
size seen at 60 mM furan is significant for all strains.
Table 3.3 shows that there is no difference between the brood sizes of N2 and 8R1,
16R2, and 16R6 at 60 mM furan. This means that none of the three mutant strains is
significantly more resistant to furan than N2 wild type worms.
Table 3.3: Dunnett’s Multiple Comparison Test (GraphPad Prism 5). N2 worms in 60 mM
furan were used as control group against which all other groups were compared.
N2 (60 mM furan) vs Mean Difference Significant?
P<0.05?
N2 - 0 mM -17.00 Yes
8R1 - 0 mM -13.00 Yes
16R2 - 0 mM -13.40 Yes
16R6 - 0 mM -15.20 Yes
8R1 - 60 mM 2.000 No
16R2 - 60 mM 1.800 No
16R6 - 60 mM -0.600 No
Furan resistance of strains 13R2, CB1467, and CB1480
Figure 3.4 (page 60) shows that without furan, there seems to be no difference between
the brood sizes of N2, 13R2, CB1467, and CB1480. Bartlett’s test for equal variances
gave a P value of 0.4848, which means that the variances are equal. Therefore, a
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one-way ANOVA could be done here as well.
Figure 3.4: Results of furan brood size assay for strains N2 (control), 13R2, CB1467,
and CB1480 (mean and SD). L4 worms were incubated in furan for four days
and the number of offspring counted. Concentrations of 0 mM (left) and 60 mM
(right) were tested in triplicate. The graph shows the results of three individual
experiments. There is no significant difference between brood sizes of N2 and 13R2.
There is no difference between the brood sizes of N2 and 13R2, CB1467 and CB1480
without furan (Table 3.4, page 61). All brood sizes are decreased at 60 mM furan. It
seems as if the brood sizes of CB1467 and CB1480 at 60 mM are different from the
brood size of N2. However, Dunnett’s multiple comparison test showed that under
these conditions, the difference is not significant (Table 3.5, page 61).
Table 3.5 also shows that there is no significant difference between the brood sizes of N2
and 13R2. Thus, there is no significant increase in furan resistance in 13R2, CB1467
and CB1480 compared to N2 wild type.
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Table 3.4: Dunnett’s Multiple Comparison Test (GraphPad Prism 5). N2 worms without furan
were used as control group against which all other groups were compared.
N2 - 0 mM furan vs Mean Difference Significant?
P<0.05?
13R2 - 0 mM -1.400 No
CB1467 - 0 mM -0.800 No
CB1480 - 0 mM -0.800 No
N2 - 60 mM 18.40 Yes
13R2 - 60 mM 18.40 Yes
CB1467 - 60 mM 14.40 Yes
CB1480 - 60 mM 12.80 Yes
Table 3.5: Dunnett’s Multiple Comparison Test (GraphPad Prism 5). N2 worms in 60 mM
furan were used as control group against which all other groups were compared.
N2 - 60 mM furan vs Mean Difference Significant?
P<0.05?
N2 - 0 mM -18.40 Yes
13R2 - 0 mM -19.80 Yes
CB1467 - 0 mM -19.20 Yes
CB1480 - 0 mM -19.20 Yes
13R2 - 60 mM 0.000 No
CB1467 - 60 mM -4.000 No
CB1480 - 60 mM -5.600 No
3.2.3 Summary
Together, these results clearly show that furan has an effect on C. elegans brood size.
Furan inhibits C. elegans egg laying with an EC50 of about 20 mM. A decrease in the
number of offspring at 60 mM furan was observed not only in N2 wild type worms
but also in the mutant strains 8R1, 13R2, 16R2, and 16R6 as well as the him-strains
CB1467 and CB1480. The furan resistance of the mutant strains generated by Cai
(2009) could not be confirmed. Therefore SNP mapping and subsequent whole genome
sequencing could not be done for any of the strains as originally planned.
It could be argued that an intermediate dose of furan (e.g. 30 mM or 45 mM) might
reveal some significant differences between N2 and the mutant strains. These concen-
trations were not tested on the mutant strains, because a selection concentration was
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needed for SNP mapping. Lower concentrations would not have decreased the brood
size of wild type worms enough to identify resistant worms.
It is also possible that with more data (and narrower error bars) the difference between
the brood sizes of CB1467 and CB1480 compared to N2 at 60 mM will be significant.
This was not further investigated as the mutation in these strains is known. Therefore
SNP mapping and whole genome sequencing with these strains would not have given
any new information.
3.3 L1 growth assay
To measure the effect of furan on C. elegans growth, L1 worms were incubated in
different concentrations of furan. After three days, the worms were imaged at 20x
magnification and photographs were taken. The size of the worms was measured and
compared to controls without furan.
3.3.1 Experimental conditions and problems
The measurements of C. elegans size were done using Adobe Photoshop and the mag-
netic lasso tool to determine the area of the worm. The size was then compared to 0 mM
furan control. Initial measurements were very inaccurate and the results were inconsis-
tent between experiments. The contrast of the worm images was not high enough for
the magnetic lasso tool to find the exact outline of the worms. Some of the worms were
not lying straight, therefore it was impossible to measure the length of the worms.
No effect of furan on C. elegans size could be seen (Figure 3.5, page 63). To improve
the results of the measurements, more sodium azide was added for the worms to com-
pletely ”relax”. This gave better data in Adobe Photoshop. Also, more worms were
photographed.
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Figure 3.5: Initial results of L1 growth assay with N2 (mean and SEM). L1 worms were
incubated in furan for 3 days. 10 worms were photographed at 20x magnification
and the area measured in Adobe Photoshop. The measurements were inaccurate
and the results were not consistent between experiments. No effect of furan on
C. elegans growth could be seen.
Figure 3.6: Results of the modified L1 growth assay with N2 (mean and SEM). L1
worms were incubated in furan for three days. 20 worms were photographed at 20x
magnification and the size measured in Adobe Photoshop. A reduction of C. elegans
size can be seen for furan concentrations from 10 mM to 45 mM, although this effect
is not statistically significant.
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3.3.2 Effect of furan on C. elegans growth
The effect of furan on C. elegans growth can be seen in Figure 3.6 (page 63). Growth
seems to be inhibited at concentrations ranging from 10 mM to 45 mM furan. Inter-
estingly, this is not true for 60 and 80 mM. At 80 mM C. elegans are even larger than
without furan. These worms do not have any obvious phenotype, e.g. they are not
dumpy, which would increase the area in the photographs and therefore influence the
measurements. However, a Dunnett’s test showed that these differences in size are not
statistically significant (Table 3.6). So far, these results have not been confirmed.
Table 3.6: Dunnett’s Multiple Comparison Test (GraphPad Prism 5). N2 worms incubated
without furan were used as control group against which all other groups were com-
pared.
0 mM furan vs Mean Difference Significant?
P<0.05?
10 mM 1850 px No
30 mM 8966 px No
45 mM 12223 px No
60 mM 4491 px No
80 mM -4415 px No
3.3.3 Summary
Growth seems to be inhibited by up to 45 mM furan in a dose-dependent manner.
At higher concentrations furan seem to enhance growth. However, this effect is not
statistically significant in this experiment. Further experiments have to be done to see
if these anomalous results prove to be true.
3.4 Furan feeding inhibition assay
The feeding inhibition assay is a very sensitive assay that can be used to monitor the
effect of a toxin on C. elegans. If wild type C. elegans feeding is inhibited by furan,
this could explain the effects seen in the brood size and growth assays.
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N2 wild type worms were incubated for 24 hours in E. coli OP50 with increasing
concentrations of furan. The OD550 of the E. coli solution was measured before and
after the experiment to monitor changes in feeding.
Figure 3.7: Results of feeding inhibition assay with N2. A mixture of worms in all
developmental stages from liquid culture were incubated in a bacterial solution
containing furan. After 24 hours the OD of the bacteria was measured. The red
data point shows the control which did not contain any worms. Furan has a dose-
dependent effect on C. elegans feeding, which is inhibited at concentrations as low
as 10 mM. This graph shows the result of a single experiment with three biological
replicates. Three independent experiments gave similar results.
The results of the feeding inhibition assay are shown in Figure 3.7. Furan inhibits
feeding of C. elegans in a dose-dependent manner. Feeding is only slightly inhib-
ited at concentrations ranging from 10 mM to 40 mM. Dunnett’s multiple comparison
test showed that the effect is statistically significant (P<0.05) for all concentrations
tested (Table 3.7, page 66). However, it is also possible that there is some lethality at
lower concentrations, e.g. affecting the larval stages. This would influence the result
and would indicate feeding inhibition where there is none. It is more likely that there is
no inhibition at concentrations ranging from 0 mM to 30 mM. Furan seems to inhibit
feeding with a NOAEL of 30-40 mM.
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Table 3.7: Dunnett’s Multiple Comparison Test (GraphPad Prism 5). N2 worms without furan
were used as control group against which all other groups were compared.
N2 - 0 mM furan vs Mean Difference Significant?
P<0.05?
10 mM 4.760 Yes
20 mM 4.099 Yes
30 mM 5.593 Yes
40 mM 6.445 Yes
60 mM 17.48 Yes
80 mM 49.04 Yes
At 80 mM furan, the OD550 reaches the same value as the control which did not contain
any worms. This means that the worms completely stop feeding at this concentration.
To calculate the EC50, mean values were normalised and the control value (bacteria
without worms) was set as top plateau of the curve. A sigmoidal curve was fitted plot-
ting the log(agonist) vs. response. In this case, the agonist was the furan concentration
and the response was the OD550. The EC50 is 69.9 mM.
Summary
Furan inhibits C. elegans feeding in a dose-dependent manner with an EC50 of about
70 mM. The maximum effect is reached at 80 mM where the worms completely stop
feeding.
3.5 GFP reporter assay
GFP reporter strains were used to measure expression levels of several genes involved
in stress response pathways in C. elegans. The worms were incubated in increasing
concentrations of furan and the fluorescence was measured. Measurements were taken
at early (4 hours), intermediate (8 hours and 16 hours) and late time points (24 hours).
Strong upregulation (2-4x) was seen for the genes used in these experiments following
incubation with other agents, e.g.:
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• cep-1, cyp-29A2, cyp-35A2, and gst-1: Zn2+
• cyp-34A9, hsp-3: dichlorvos
• C11E4.1, hsp-16.2, and sod -4: Fe3+
• gst-4 and sod -1: Cr3+
• hsp-3, sod -3: Cu2+
• sod -4: Cd2+
Figure 3.8: Live output of GFP reporter assay from the Wallac 1420 Manager soft-
ware.
3.5.1 Considerations
As the worms are incubated without a food source, they are under mild stress even
without the addition of any toxicant. This explains why for some strains the basal
fluorescence changes over time. The flourescene at a given furan concentration must
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therefore be compared to the value at 0 mM furan at the same time point rather than
the value for the same concentration at an earlier time point.
Usually, the measurements at different time points are done with the same set of worms.
Because of the high volatility of furan, a separate plate was used for each measurement.
This method possibly increases the variability between results, as the number of worms
in each well might vary slightly. However, transferring worms between plates results
in the loss of a certain number of worms which remain in the pipette tip and in the
wells. If measurements are taken at several time points, the number of worms might
decrease significantly with each measurement. Using individual plates for each time
point therefore decreases the possibility of artefacts.
3.5.2 Cytochrome P450 induction
cyp-29A2, cyp-34A9, and cyp-35A2 encode cytochrome P450 enzymes. It is known
that furan is metabolised by a cytochrome P450 in humans, therefore one would expect
to find one of the cyp-genes to be induced by furan. Menzel et al. (2001) found that
CYP35 genes are strongly inducible by different xenobiotics. It was therefore expected
to be induced by furan as well.
Figures 3.9 to 3.11 (pages 69 and 70) show the results for the GFP reporter assays for
the three cyp-genes. There is no induction at any concentration or time point for these
three genes.
3.5.3 Glutathione S-transferase induction
GST-1 and GST-4 are glutathione S-transferases. GSTs catalyse the conjugation of
GSH to usually hydrophobic and electrophilic compounds. Furan is thought to be
activated to an electrophilic intermediate by a cytochrome P450. The intermediate
would then be conjugated to GSH (Carfagna et al., 1993) which would result in an
induction of gst-genes.
68
Figure 3.9: Results of GFP reporter assay for gene cyp-29A2 (mean and SD). The
fluorescence was measured after 4, 8, 16, and 24 hours.
Figure 3.10: Results of GFP reporter assay for gene cyp-34A9 (mean and SD). The
fluorescence was measured after 4, 8, 16, and 24 hours.
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Figure 3.11: Results of GFP reporter assay for gene cyp-35A2 (mean and SD). The
fluorescence was measured after 4, 8, 16, and 24 hours.
Figures 3.12 and 3.13 (page 71) show the results of the GFP reporter assay for the
genes gst-1 and gst-4. gst-1 basal expression slightly increases over time. However,
neither gene is upregulated following exposure of C. elegans to furan over 24 hours.
3.5.4 P53 induction
In C. elegans cep-1 (C. elegans p53-like-1) encodes an ortholog of the human tumor
suppressor p53. P53 is also called the ”guardian of the genome”. It promotes DNA
damage-induced apoptosis. cep-1 seems to be the only p53 in C. elegans (Derry et al.,
2001; WormBase, 29/04/2010). If cep-1 were to be induced by furan, this might be
evidence for a genotoxic mode of action.
The result of this assay is shown in Figure 3.14 (page 72). There is no induction at any
concentration or time point.
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Figure 3.12: Results of GFP reporter assay for gene gst-1 (mean and SD). The fluo-
rescence was measured after 4, 8, 16, and 24 hours. The basal expression increases
slightly over time, but no effect of furan could be observed.
Figure 3.13: Results of GFP reporter assay for gene gst-4 (mean and SD). The fluo-
rescence was measured after 4, 8, 16, and 24 hours.
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Figure 3.14: Results of GFP reporter assay for gene cep-1 (mean and SD). The
fluorescence was measured after 4, 8, 16, and 24 hours.
3.5.5 Induction of heat shock proteins
Heat shock proteins (HSP) are proteins whose expression is increased when cells are
exposed to increased temperatures or other stresses. Here, the induction of hsp-3 and
hsp-16.2 was examined.
The results are shown in Figures 3.15 and 3.16 (page 73). hsp-3 shows a slight decrease
in its basal expression over time. The expression of both genes, however, is not affected
by furan.
3.5.6 Superoxide dismutase (SOD) induction
Superoxide is a reactive oxygen species in the cell. Superoxide dismutases (SODs) are a
class of enzymes that catalyze the dismutation of superoxide into oxygen and hydrogen
peroxide. Therefore, they are important antioxidants. In C. elegans sod genes seem to
be involved in a number of processes. The three sod genes tested were sod -1, sod -3, and
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Figure 3.15: Results of GFP reporter assay for gene hsp-3 (mean and SD). The
fluorescence was measured after 4, 8, 16, and 24 hours. The expression of hsp-3
increases slightly over time, but no effect of furan could be observed.
Figure 3.16: Results of GFP reporter assay for gene hsp-16.2 (mean and SD). The
fluorescence was measured after 4, 8, 16, and 24 hours.
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sod -4. Mn-SOD enzymes such as SOD-3 are mitochondrial, whereas Cu2+/Zn2+-SOD
enzymes are cytosolic. In C. elegans, SOD-4 appears to be extracellular. (WormBase,
29/04/2010).
None of the three genes tested was induced by furan (Figures 3.17 to 3.19, pages 74 to
75).
Figure 3.17: Results of GFP reporter assay for gene sod-1 (mean and SD). The fluo-
rescence was measured after 4, 8, 16, and 24 hours.
3.5.7 Glutathione peroxidase induction
Another enzyme frequently induced during oxidative stress is glutathione peroxidase.
Of at least twelve such genes in C. elegans (so far uncurated), the C11E4.1 gene (des-
ignated GPB) is expressed mainly in the intestine and is strongly induced by may
stressors (de Pomerai et al., unpublished results).
As can be seen in Figure 3.20 (page 76), GPB was not induced by furan.
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Figure 3.18: Results of GFP reporter assay for gene sod-3 (mean and SD). The fluo-
rescence was measured after 4, 8, 16, and 24 hours.
Figure 3.19: Results of GFP reporter assay for gene sod-4 (mean and SD). The fluo-
rescence was measured after 4, 8, 16, and 24 hours.
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Figure 3.20: Results of GFP reporter assay for gene GPB (mean and SD). The fluo-
rescence was measured after 4, 8, 16, and 24 hours.
3.5.8 Summary
The GFP reporter assay is inexpensive and easy to perform but did not yield a positive
result in the case of furan, since none of the genes tested was induced after exposure of
C. elegans to furan.
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4 Discussion
4.1 C. elegans as a model organism to study the toxicity
of furan
The choice to use C. elegans as a model organism to investigate the mechanism of
furan toxicity was rational since this model is now widely used in toxicity testing and
drug screening (Artal-Sanz et al., 2006; Boyd et al., 2010a,b; Ura et al., 2002). Being
simple enough to be studied in great detail, C. elegans is nevertheless a multicellular
eukaryotic organism. Many of its genes are highly conserved and findings can therefore
be extrapolated (with caution) to other organisms, including humans.
4.2 Optimisation of protocols
Optimising protocols is a very time-consuming process which usually takes longer than
the actual experiment. It was difficult to establish a working protocol for the brood
size assay. Initial results were highly variable and no reduction in brood size could be
seen. It was not possible to confirm the results of earlier experiments done by Budd
(2008) and Cai (2009). A reason for these differences in the results had to be found
and a series of assays was run to find the optimal conditions. The high volatility of
furan made it necessary to apply extra precautions. An increase in furan concentration
and the use of individual plates for each test concentration finally led to reliable and
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reproducible results. Similar problems were encountered with the L1 growth assay.
These optimisation experiments took a good deal of the time available for the project.
4.3 Identification of genes conferring resistance to furan
The reported furan resistance of the C. elegans mutants generated by Cai (2009) could
not be confirmed for any of the four strains (Section 3.2). One possible reason for this
might be the use of ethanol as solvent for furan. Ethanol itself has an effect on brood
size (Davies et al., 2003) and there might be an additive or synergic effect with furan.
Notably, as indicated in Table 2.2 (page 44), the different furan test concentrations
using Cai’s original procedure each involved a different furan:ethanol ratio, making the
results difficult to interpret. It is also possible that the mutation caused a change which
made the worms sensitive to freezing. This would also explain the low recovery rates
from frozen stocks (Section 3.1).
As the mutant strains were shown not to be any more resistant to furan than N2 wild-
type worms, they could not be used to map the mutations and identify any of the genes
possibly involved in furan metabolism in C. elegans. Therefore, no more work could be
done on this part of the project.
As can be seen from the dose response experiment in Figure 3.2 (page 57), there clearly
is a toxic effect of furan on C. elegans. It was therefore decided to change the initial
objectives of the project and to further characterise this effect using different assays to
measure stress response in C. elegans.
4.4 Subcellular effects of furan on C. elegans
GFP reporter assays offer an inexpensive alternative to gene arrays. However, they
have some limitations as only a small number of genes can be monitored. The range
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of GFP reporter genes currently available largely reflects those known to be strongly
inducible under a range of test conditions (e.g. the cyp genes identified as xenobiotic
inducible by Menzel et al. (2001)).
Leiers et al. (2003) found that the RNAi silencing of Ce-GST-p24 was not compensated
for by other GSTs. This shows that there is a high degree of specialization of the
individual enzymes within the GST superfamily in C. elegans. As there are 44 genes
coding for GST proteins, it is not surprising that no upregulation could be found in
any of the two tested gst-genes. The same applies to the three P450 genes used in this
experiment. None of them is induced after incubation of the worms in furan. However,
there are over 80 P450 genes in C. elegans WormBase (29/04/2010). It would therefore
be worth looking at more of the P450 genes. It is very likely that one or more of them
are involved in furan metabolism in C. elegans.
cep-1 was also not induced after exposure of C. elegans to furan. As cep-1 is the only
known p53 gene in C. elegans, this might suggest that furan is not genotoxic. Since
furan was only used at sublethal concentrations, DNA repair might be induced if furan
had any genotoxic effect.
4.5 Visible and behavioural effects of furan on C. elegans
It could be shown that furan inhibits wild type C. elegans feeding and egg laying.
Feeding is reduced at concentrations as low as 10 mM and completely inhibited at
80 mM, with an EC50 of about 70 mM. Egg laying is greatly inhibited at 60 mM
with an EC50 of about 20 mM. Thus, egg laying appears to be more sensitive to furan
than feeding. Given that feeding was greatly inhibited at higher furan concentrations,
one would expect a similar effect on C. elegans growth. Interestingly, this effect was
not statistically significant. However, this result has not been confirmed and further
experiments are required.
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4.6 Comparison to published data
There are several issues that has to be taken into account when comparing the data
presented in this work to data that has been published in the literature.
• All furan concentrations given in the literature are instantaneous concentrations
which will rapidly reduce in vivo in mice and rats.
• It is not known if furan is effectively absorbed in C. elegans so the concentrations
used in this work are also only instantaneous.
• The high volatility of furan leads to a certain loss over time.
The precise amount of furan in rodents and worms obviously affects the comparison.
Therefore, only a rough estimation can be made. In addition, experiments in rodents
can be done over several weeks or months, the NTP study even includes an experiment
over two years (National Toxicology Program, 1993). C. elegans average life span is
about 2-3 weeks, so long term effects can not be monitored.
In all rodent experiments, doses were in the range of 0 to 200 mg/kg bwt per day. For
example, in the NTP study (National Toxicology Program, 1993) pathological changes
in rats and mice could be seen with 20-160 mg/kg bwt per day for 16 days. Doses as
low as 2-8 mg/kg bwt led to carcinomas when given over two years.
Furan has a molecular weight of 68.08 g/mol, so 100 mM furan in my experiments
equals 6.8 g furan per kg body weight in rodents. The lethal dose of 90 mM furan
found in my experiments roughly equals 6.12 g/kg bwt in rodents. This means that the
doses effective in the C. elegans experiments were ten to thousand times higher than
those used in mice and rats.
It is possible that C. elegans are less sensitive to furan, e.g. because the uptake of furan
from the environment is low. Another reason for these differences might be that there
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are special detoxification mechanisms that do not exist in other animals (Lindblom &
Dodd, 2006).
It is important to note that the experiments done in this project did not aim to find
an EC or LOAEL that can be applied to rodents or even humans but to identify the
pathways of furan metabolism and toxicity. Therefore, direct comparability in this case
is not necessary.
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5 Future Work
5.1 SNP mapping
The findings of Cai (2009) that 30 mM furan can be used as a selection concentration
for furan-resistant mutants could not be confirmed. Unfortunately, the supposedly re-
sistant strains did not show any increase in furan resistance compared to N2 wild type
worms. However, the identification of genes conferring resistance to furan could give
further insight into the mechanism of furan toxicity. Therefore, new mutant strains
should be generated and screened for furan resistance. A selection concentration be-
tween 60 mM and 90 mM is recommended for the brood size assay, although a concen-
tration that does not kill adult worms, but reduces brood size in N2 wild-type worms
to 0 has not yet been determined.
If mutants could be generated that show furan resistance, these mutations could be
mapped to determine the identity of the gene. Single nucleotide polymorphism (SNP)
mapping would be the technique of choice to identify the chromosome and the rough
position of the gene affected. SNPs are in fact single nucleotide changes, usually ”C
to T” or ”A to G”. However changes such as an insertion or deletion of a nucleotide
are also common. SNP mapping was first done in 2001 (Wicks et al., 2001). DNA
polymorphisms between the N2 wild type and a closely related strain such as the
Hawaiian CB4856 are used as genetic markers. They are approximately as dense as
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genes and do not have an associated phenotype (Davis et al., 2005). Initially, at least
three SNPs from each chromosome would be used, one from each arm and one from
the centre. Once the position of the mutation has been mapped to one arm of a
chromosome, more markers can be used to narrow down the region. In a final step,
whole genome sequencing of both the N2 reference strain and the mutant would make
it possible to identify the mutated gene. Identifying this gene could give an insight into
furan metabolism in C. elegans and possibly in humans.
5.2 DNA microarrays
The results from feeding inhibition and GFP reporter assays show that there is an effect
of furan on C. elegans. It is therefore worth investigating the effect of furan on more
genes known to be involved in stress response in C. elegans. Due to time limitations
only a small number of genes could be tested in the GFP reporter assay. To enable
the screening of more genes at a time, a DNA microarray would be the best choice.
Rather than doing a genome wide screen, research should initially focus on P450 genes,
glutathione transferase genes and genes involved in DNA repair. This would essentially
be a stress response gene chip for C. elegans which could also be used to look at other
stressors. Looking at these genes in C. elegans, the proposed mechanism of furan
metabolism could be confirmed. In a second step, a genome wide screen could reveal
unknown pathways of furan toxicity.
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